PVLA

Palvella Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$123.46

Market Cap

$1.46B

Beta

-0.29

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+21.21%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-1.32%

Debt / Equity0.02

Interest Coverage-6.6x

No credit card required

Already have an account? Sign in to view the full analysis for PVLA.